Avelox and Conversion disorder - a phase IV clinical study of FDA data

Summary:

Conversion disorder is reported as a side effect among people who take Avelox (moxifloxacin hydrochloride), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Flonase, and have Chronic obstructive pulmonary disease.

The phase IV clinical study analyzes which people have Conversion disorder when taking Avelox. It is created by eHealthMe based on reports of 27,890 people who have side effects when taking Avelox from the FDA, and is updated regularly.

What is Avelox?

Avelox has active ingredients of moxifloxacin hydrochloride. It is often used in sinusitis. eHealthMe is studying from 28,651 Avelox users. Check the latest studies of Avelox.

What is Conversion disorder?

Conversion disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause) is found to be associated with 292 drugs and 601 conditions by eHealthMe. Check the latest studies of Conversion disorder.

On Apr, 26, 2026

27,890 people reported to have side effects when taking Avelox.
Among them, 12 people (0.04%) have Conversion disorder.

Among these 12 people:

How long have people been on Avelox when they have Conversion disorder? *

What is the gender of people who have Conversion disorder when taking Avelox? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Conversion disorder when taking Avelox? *

What are other drugs people take besides Avelox? *

What are other side effects people have besides Conversion disorder? *

Stress And Anxiety: 3 people, 25.00%
Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 3 people, 25.00%
Agitation (state of anxiety or nervous excitement): 2 people, 16.67%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 16.67%
Drug Screen Positive: 2 people, 16.67%
Crying: 2 people, 16.67%
White Blood Cells Urine Positive: 1 person, 8.33%
Chronic Renal Failure (kidney failure): 1 person, 8.33%
Dyspnea (difficult or laboured breathing): 1 person, 8.33%
Dizziness: 1 person, 8.33%

What are the existing conditions these people have? *

Depression: 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
Upper Respiratory Tract Inflammation: 1 person, 8.33%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 1 person, 8.33%
Sciatic Nerve Neuropathy (sciatic nerve damage): 1 person, 8.33%
Pain: 1 person, 8.33%
Otitis (ear infection): 1 person, 8.33%
Neuropathy Peripheral (surface nerve damage): 1 person, 8.33%
Neuralgia (pain in one or more nerves): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Avelox and have Conversion disorder?

- Check whether Conversion disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avelox:

Avelox (28,651 reports)

Browse all side effects of Avelox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conversion disorder:

Conversion disorder (292 drugs)

Browse all the conditions that are associated with Conversion disorder:

Conversion disorder (601 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on moxifloxacin hydrochloride (the active ingredients of Avelox) and Avelox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.